Local Institution - 0169
Koto-ku, Tokyo 135-8550
1 studies enrolling now · 1 studies all time
What they study most
Urothelial Cancer
Studies at this site
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
— Recruiting now